期刊文献+

右旋美托咪啶的镇静效应及其对全麻镇静深度的影响 被引量:105

The effect of dexmedetomidine on sedation and anaesthetic depth in patients undergoing general anesthesia
下载PDF
导出
摘要 目的研究右旋美托咪啶(Dex)的镇静效应及其对全麻患者麻醉深度的影响。方法择期手术的患者60例(ASAⅠ~Ⅱ级),根据不同用药时期情况均分为镇静组和麻醉组,镇静组30例又分为Dex组(D1组)和对照组(C1组):D1组静脉泵注Dex负荷剂量0.4μg/kg(5min注完),然后以0.4μg·kg-1·h-1维持静注30min;C1组以同样方式输注生理盐水。记录不同时点的脑电双频指数(BIS)、MAP、HR,并对患者进行OAA/S、Ramesay镇静评分。麻醉组30例全麻患者也随机分为D2和C2组:D2组术中静脉Dex0.4μg/kg5min注完;C2组输注生理盐水。术中以丙泊酚靶控输注(TCI)和雷米芬太尼静脉维持麻醉,调节丙泊酚血浆靶控浓度(Ct),使BIS维持在50±3。结果D1组Dex负荷剂量输注后以及维持期间BIS比基础值降低17.0%~30.9%(P<0.05),镇静效应明显,OAA/S和Ramsay镇静评分明显降低(P<0.05);D2组患者麻醉前BIS为92±1,给予Dex后BIS由51±2降至42±16,C2组则仍为51±3。D2组丙泊酚的用量比C2组减少8%~14%(P<0.05)。结论Dex对清醒患者产生明显镇静效应,并能加深全麻患者的麻醉深度,减少丙泊酚TCI的用量。 Objective To observe the effects of dexmedetomidine (Dex) on the sedation and anaesthetic depth during general anesthesia. Methods Thirty patients (ASAⅠ-Ⅱ) who were not to he in anaesthesia randomly divided into group D1 (intravenous 0.4μg·kg^-1·h^-1 Dex for 30 min after a loading dose of 0.4μg/kg) and group C1 (0.9% normal saline was given as control). The hispectrial index (BIS), HR, MAP, SpO2, OAA/S, Ramsay sedation scale were monitored,before Dex infusion (T0) and after loading (T1), and at 5,10,15,20,25,30 rain (T2 -T7 ) after continuous infusion. Thirty adult patients (ASAⅠ-Ⅱ) scheduled for elective thyroidectomy were randomized double blindly into group D2 and group C2 (given drugs as in group D1 and C1). Anesthesia was induced by target controlled infusion (TCI) with propofol and remifentanyl to maintain BIS at 50±3. Results In group D1 , BIS decreased by 17.0%-30.9% (P〈0.05) compared with that before, OAA/S and Ram say scale also decreased significantly (P〈0.05). In group D2, administration of Dex resulted in a decrease in BIS from 51±2 to 42±16 (P〈0. 01 ). During subsequent surgery, propofol requirements were reduced by 8%-14%(P〈20.05) in group D2. Conclusion Loading dose Dex 0.4μg/kg followed by 0. 4μg·kg^-1·h^-1 infusion caused sedation. The increase in anaesthetic depth given by Dex can be measured with BIS,increased anesthesia depth and reduced propofol requirement.
出处 《临床麻醉学杂志》 CAS CSCD 2006年第1期10-12,共3页 Journal of Clinical Anesthesiology
基金 广东省医学科研基金资助项目(A200571)
关键词 右旋美托咪啶 镇静 脑电双频指数 Dexmedetomidine Sedation Bispectral index
  • 相关文献

参考文献13

  • 1Ilfeld BM, Moray TE, Thannikary LJ, at al. Clonidine added to a continuous interscalene ropivacaine perineural infusion to improve postoperative analgesia: a randomized, doubleblind,controlled study. Anesth Analg, 2005, 100:1172-1178. 被引量:1
  • 2Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic and analgesic properties of small dose dexmedetomidine infusions.Anesth Analg,2000,90:699-705. 被引量:1
  • 3Ebert TJ, Hall JE, Barney JA, et al. The effects of increase plasma concentration of dexmedetomidine in humans. Anesthesiology, 2000, 93: 382-394. 被引量:1
  • 4Correa Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an α2 agonist, is mediated in the locus eoer uleus in rats. Anesthesiology, 1992, 76: 948-952. 被引量:1
  • 5Hayashi Y, Rabin BC, Guo TZ, et al. Role of pertussis toxinsensitive G-proteins in the analgesic and anesthetic action of α2-adrenergic agonlsts in the rat, Anesthesiology, 1995, 83: 816-822. 被引量:1
  • 6Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg, 2002, 95: 461-466. 被引量:1
  • 7Khan ZP, Munday IT, Jones RM, et al, Effects of dexmedetomidine on isoflurane requirements in healthy volunteers, 1:Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth, 1999, 83: 372-380. 被引量:1
  • 8Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia, 1999, 54:1136-1142. 被引量:1
  • 9Fragen RJ, Fitzgerald PC. Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults age 55 to 70 years. J ClinAnesth, 1999, 11: 466-470. 被引量:1
  • 10Durra S,Karol MD,Cohen T,et al. Effect of dexrnedetomine on propofol requirements in healthy subiects. J Pharm Sci, 2001,90:172-181. 被引量:1

同被引文献646

引证文献105

二级引证文献1073

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部